stockrowThe Ensign Group, Inc.
ENSG Healthcare Medical Care Facilities
The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.
- Revenue
- +14.5%
- EPS
- +23.6%
- Free cash flow
- +89.2%
- Total debt
- +39.2%
Quarter to September 2026, against a year earlier
Follow ENSG
Alert me
The Ensign Group, Inc. (ENSG) EPS (diluted)
The Ensign Group, Inc.'s EPS (diluted) for fiscal 2025 was $5.84, up 14.1% from $5.12 in fiscal 2024. Over the twelve months to 30 September 2026 it was $6.72. Over the past ten years it has ranged from $0.77 (fiscal 2017) to $5.84 (fiscal 2025) — the current reading is the highest in ten years. The Ensign Group, Inc. ranks 8th of 48 Medical Care Facilities companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $5.84 | 14.06% |
| FY2024 | $5.12 | 40.27% |
| FY2023 | $3.65 | (7.59%) |
| FY2022 | $3.95 | 15.50% |
| FY2021 | $3.42 | 11.76% |
| FY2020 | $3.06 | 55.33% |
| FY2019 | $1.97 | 15.88% |
| FY2018 | $1.70 | 120.78% |
| FY2017 | $0.77 | (19.79%) |
| FY2016 | $0.96 | (9.43%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $1.76 | 4.77% |
| Jun 2026 | $1.68 | 0.60% |
| Mar 2026 | $1.67 | 3.73% |
| Dec 2025 | $1.61 | 13.38% |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| UHS Universal Health Services, Inc. compare | $23.99 |
| CHE Chemed Corporation compare | $20.90 |
| DVA DaVita Inc. compare | $13.58 |
| ENSG The Ensign Group, Inc. | $6.72 |
| EHC Encompass Health Corporation compare | $6.40 |
| FMS Fresenius Medical Care AG & Co. KGaA compare | $1.87 |
| PACS PACS Group, Inc. compare | $1.77 |
| CON Concentra Group Holdings Parent, Inc. compare | $1.69 |
| LFST LifeStance Health Group, Inc. compare | $0.19 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on ENSG
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement